NSIS B — Novozymes A/S Balance Sheet

0.000.00%

Last trade - 00:00

Basic MaterialsBalancedLarge CapHigh Flyer

Annual balance sheet for Novozymes A/S, fiscal year end - December 31st, EUR millions except per share, conversion factor applied.

	2020 December 31st	2021 December 31st	2022 December 31st	2023 December 31st	2024 December 31st
Period Length:	—	—	—	—	—
Source:	ARS	ARS	ARS	ARS	ARS
Standards:	IFRS	IFRS	IFRS	IFRS	IFRS
Status:	fx Final	fx Final	fx Final	fx Final	Final
Cash and Equivalents
Short Term Investments
Cash and Short Term Investments	175	140	151	155	284
Net Total Accounts Receivable
Net Total Receivables	434	510	581	583	863
Total Inventory
Total Other Current Assets
Total Current Assets	929	1,052	1,243	1,269	1,879
Gross Property, Plant And Equipment
Accumulated Depreciation
Net Property, Plant And Equipment	1,292	1,370	1,624	1,653	2,968
Net Goodwill
Net Intangible Assets
Long Term Investments
Long Term Notes Receivable
Other Long Term Assets
Total Assets	2,756	3,331	3,764	3,809	15,196
Accounts Payable
Accrued Expenses
Notes Payable / Short Term Debt
Current Portion of Long Term Debt / Capital Leases
Total Other Current Liabilities
Total Current Liabilities	559	763	937	974	1,088
Long Term Debt
Capital Lease Obligations
Total Long Term Debt
Total Debt
Deferred Income Tax
Minority Interest
Total Other Liabilities
Total Liabilities	1,247	1,740	1,903	1,934	4,020
Common Stock
Retained Earnings (Accumulated Deficit)
Other Equity
Total Equity	1,510	1,591	1,861	1,875	11,176
Total Liabilities & Shareholders' Equity	2,756	3,331	3,764	3,809	15,196
Total Common Shares Outstanding